We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




3-D Mammography Device Cleared by FDA

By HospiMedica staff writers
Posted on 20 Apr 2001
A new type of mammography device, based on technology originally developed to pinpoint tooth decay, has been cleared by the U.S. More...
Food and Drug Administration (FDA). The technology, called tuned-aperture computed tomography (TACT), allows radiologists to see tumors within the dense part of the breast or in other breast regions that might otherwise be obscured by overlying tissue.

The new technology produces a series of electronic slices that image each portion of the breast in great detail and reconstructs a 3-D image from a series of 2-D images. The technology was developed by Richard Webber, D.D.S., professor of dentistry and radiologic sciences at Wake Forest University School of Medicine (Winston-Salem, NC, USA), and has been licensed by the school to Instrumentarium Imaging (Tuusula, Finland). Instrumentarium calls its TACT device the Delta 32 TACT 3-D breast imaging system, which will be available exclusively on Instrumentarium's Diamond Breast Care System.

According to Dean F. Stell, assistant director of the Office of Technology Asset Management at Wake Forest, TACT is the first imaging system to allow interactive 3-D visualization of breast tissue. "This technology has the potential to cut down on unnecessary biopsies,” he said.


Related Links:
Instrumentarium

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.